Listen to audio brief:

On May 12, 2025, President Donald J. Trump announced an Executive Order aimed at lowering prescription drug prices for Americans. The order directs the U.S. Trade Representative and Secretary of Commerce to prevent foreign countries from undermining U.S. drug prices and allows Americans to purchase drugs directly from manufacturers at a “Most-Favored-Nation” price. This initiative builds on previous efforts to reduce price disparities and includes provisions for Medicaid, reflecting the administration’s commitment to ensuring fair drug pricing for American patients and taxpayers.

Original: article